Simris Biologics identifies and develops applications for novel, natural biologics sourced from cyanobacteria and microalgae. The company develops technology platforms based on these compounds and partners with customers to create final products.
products_or_servicesIdentification and development of natural biologics, technology platforms, license agreements for product development, antibody drug conjugates, cyanobacterial toxin standards and reagents.
Sweden